The association between cardiovascular disease gene mutations and recurrent pregnancy loss in the Lebanese population

Mol Biol Rep. 2018 Oct;45(5):911-916. doi: 10.1007/s11033-018-4237-1. Epub 2018 Jul 4.

Abstract

Recurrent pregnancy loss (RPL) is a problem affecting up to 5% of women of childbearing age due to many factors. Studies have shown that RPL and cardiovascular disease (CVD) may have shared risk factors. We compared the prevalence of 12 cardiovascular disease related gene mutations in patients with a history of RPL to normal controls in a major tertiary care center in Lebanon. The CVD StripAssay (ViennaLab, Austria) was used to analyze the CVD genes on 70 women with RPL history as part of the initial routine workup for recurrent miscarriage at the American University of Beirut Medical Center. The obtained results were compared with data of controls from the Lebanese population using Fisher's exact test and Chi square analysis. Two genes of the CVD panel demonstrated a strong relationship with RPL, including, MTHFR (C677T homozygosity, A1298C homozygosity, and compound heterozygosity for C677T and A1298C) and Factor II (heterozygosity for G20210A). Moreover, a protective role of positive APO-E3 isoform was observed. This study is the first in the Lebanese population in associating RPL with a large panel of CVD related genes.

Keywords: Cardiovascular; Genes; Loss; Pregnancy.

MeSH terms

  • Abortion, Habitual / epidemiology
  • Abortion, Habitual / genetics*
  • Adult
  • Apolipoprotein E3 / genetics
  • Cardiovascular Diseases / genetics*
  • Cross-Sectional Studies
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Lebanon / epidemiology
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Mutation Rate
  • Mutation*
  • Pregnancy
  • Prothrombin / genetics*
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • Apolipoprotein E3
  • Prothrombin
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)